The thing that is breaking digital health is marketing.
One of the most common problems I have seen in digital health is awareness. That’s a big reason that you’ll hear companies talking about “covered lives,” meaning the number of people eligible to use their service via their health plan or employer, versus the number that actually uses them.
That actual numbers of patients who use the service - and not just once for a lark once or twice - is typically very low. Depressingly so.
Is that digital health’s fault? Are founders simply failing to create products that anyone wants to use? Unlikely. Perhaps it’s true for some companies. But that’s way too simplistic for most. I’ve met with plenty of founders with incredible health products, which could do a lot of good in the world if patients discovered them.
`Upcoming Sessions
Live conversations with the people shaping healthcare.
Is It Finally the Moment for Alternative Plan Design?
Employers are under growing pressure to control healthcare costs while improving access, outcomes, and the member experience. That has renewed interest in
Type 2 Diabetes & Cardiometabolic Care: Wearables, AI & GLP-1s
The rise of wearables, GLP-1s, and AI is reshaping treatment for Type 2 diabetes, weight loss, and metabolic disease. We have
Verifying AI in Medicine: Is Healthcare AI Actually Ready for Deployment?
Is AI ready for real-world clinical care? Dr. Zak Kohane and Protege’s Engy Ziedan debate what it takes to safely trust AI in diagnosis and treatment, from benchmark performance and clinical evidence to whether we’re holding AI to a higher standard than humans.
Why Are Hospitals Hiring Chief AI Officers?
As AI moves from pilots into day-to-day healthcare operations, health systems are having to decide who should actually own the
Where are AI Agents Actually Working in Healthcare, and Why?
While the healthcare industry remains locked in a high-level debate over the theoretical potential of artificial intelligence, a select group of
Top Employers Share What Healthcare Startups Need to Know in 2026
As enterprise health purchasers face volatile medical cost trends and tightening operational margins, the standard vendor pitch of "improved clinical efficiency&
Peptide Therapy: Where Do We Go From Here?
Watch the full webinar Peptide therapies have moved from niche biohacking circles into mainstream medicine, reshaping conversations around weight management, metabolic health,
Not everyone can access the top 1% of physicians. Will AI change that?
Historically, top-tier medical expertise was limited by wealth and geography. As AI reshapes healthcare delivery, a vital question emerges: can it democratize intelligence to give everyone access to the caliber of care typically reserved for the top 1%?
Privacy AI and the Future of HIPAA
Watch the Full Webinar As AI reshapes healthcare and more patient data flows beyond traditional clinical settings, the rules governing privacy, access,